What is the optimal anticoagulation intensity to prevent stroke in patients with atrial fibrillation >=75 versus <75 years old? The anticoagulation and risk factors in atrial fibrillation (ATRIA) study

Prevalence of Diagnosed Atrial Fibrillat

Prevalence of Diagnosed Atrial Fibrillation in Adults: National Implications for Rhythm Management and Stroke Prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study

✍ Go, A. S. 📂 Article 📅 2001 🏛 American Medical Association 🌐 English ⚖ 184 KB

Which is the Optimal Therapy to Prevent

Which is the Optimal Therapy to Prevent Thromboembolism After Atrial Fibrillation Ablation Procedures in Low Stroke Risk Patients, Anticoagulation or Antiplatelet Therapy?

✍ YASUO OKUMURA 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Performance of the HEMORR2HAGES, ATRIA,

Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk–Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation: The AMADEUS (Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation) Study

✍ Stavros Apostolakis; Deirdre A. Lane; Yutao Guo; Harry Buller; Gregory Y.H. Lip 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 704 KB

Performance of the HEMORR2HAGES, ATRIA,

Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk–Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation: The AMADEUS (Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation) Study

✍ Stavros Apostolakis; Deirdre A. Lane; Yutao Guo; Harry Buller; Gregory Y.H. Lip 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 704 KB

## Objectives: The objective of this study was to compare the predictive performance of bleeding risk-estimation tools in a cohort of patients with atrial fibrillation (af) undergoing anticoagulation. ## Background: Three bleeding risk-prediction schemes have been derived for and validated in pat

Corrigendum to “Investigation of optimal

Corrigendum to “Investigation of optimal anticoagulation strategy for stroke prevention in Japanese patients with atrial fibrillation—The J-RHYTHM Registry study design” [J. Cardiol. 57 (2011) 95–99]

✍ Hirotsugu Atarashi; Hiroshi Inoue; Ken Okumura; Takeshi Yamashita; Hideki Origas 📂 Article 📅 2011 🏛 Elsevier 🌐 Japanese ⚖ 100 KB

Letter by Apostolakis et al Regarding Ar

Letter by Apostolakis et al Regarding Article, “Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R 2 CHADS 2 Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study Cohorts”

✍ Apostolakis, Stavros ;Lane, Deirdre A. ;Banerjee, Amitava 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 419 KB